Search for symbols and tags, and bookmark them to monitor closely

Eli Lilly Shares Rise After Zepbound Sleep Apnea Approval

Eli Lilly sees stock surge as Zepbound receives regulatory approval for treating sleep apnea. Discover how this impacts the healthcare market.

A sleek, modern representation of a rising stock chart intertwined with medical symbols, reflecting
Eli Lilly Shares Rise After Zepbound Sleep Apnea Approval

Eli Lilly rose following regulatory approval of Zepbound for sleep apnea.

Source